公司資料
Atossa Therapeutics, Inc. 股價、新聞與催化劑
- 股票代碼:
- ATOS
- 交易所:
- NASDAQ
- 產業:
- MedTech
- 所在地:
- United States
股票表現
2.40 USD (-0.83%)
收盤價
最後更新: 2026年9月17日
41.8M USD
市值
股價為何變動
截至 2026年9月17日，ATOS 下跌 0.83%，收於 $2.40。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Atossa Therapeutics is a breast-cancer company focused on therapies and diagnostics in oncology and women’s health. Its business is centered on targeted disease biology and cancer-related development.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Atossa sits in specialty oncology biotechnology.
商業模式特徵
The company depends on clinical data, biomarker strategy, and the ability to create a focused breast-cancer story.
生技產業定位
Atossa is a catalyst-sensitive oncology name whose valuation is driven by data and differentiation.
未來催化劑
- Atossa’s catalysts are endoxifen and any breast-cancer development progress that keeps the selective-estrogen-receptor story alive. The next update matters because the company still needs stronger human evidence.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。